Horizon and Rutgers Uni form gene editing partnership
Horizon Discovery and Rutgers University signed a partnership deal to commercialise a new gene editing technology.
Read More
Tag: gene editing
Gilead, Precision to co-develop hepatitis B therapies
Gilead and Precision BioSciences are to work together on developing gene-editing treatments against hepatitis B.
Read More
UK panel says human embryo editing ‘morally permissible’
An independent ethics panel in the UK has concluded that genome editing to influence the characteristics of a future person could be “morally permissible”.
Read More
MHRA authorises in vivo genome editing trial
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted permission for initiation of Europe’s first in vivo genome editing study.
Read More
- UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies
- Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage
- Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
- MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
